Clinical Trial Update: Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer [Phase 1]

View source ↗

Summary

This clinical trial entry describes a Phase 1 study evaluating BNT116 as a single agent and in combination regimens for advanced non-small cell lung cancer. The…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• BNT116

Snippet

Sponsor: BioNTech SE | Conditions: Non-Small Cell Lung Cancer | Phase 1 | Status: RECRUITING